Does topical diclofenac (Nonsteroidal Anti-Inflammatory Drug (NSAID)) gel cause less gastritis than oral ibuprofen (NSAID)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Yes, diclofenac gel typically causes less gastritis than oral ibuprofen. Diclofenac gel is applied topically to the skin, allowing the medication to penetrate locally to the affected area while minimizing systemic absorption. This localized delivery means that much less of the drug enters the bloodstream and reaches the stomach lining, significantly reducing the risk of gastritis and other gastrointestinal side effects. In contrast, oral ibuprofen is absorbed through the digestive system, where it directly contacts the stomach lining and inhibits protective prostaglandins throughout the body, increasing the risk of gastritis, ulcers, and bleeding.

Key Points to Consider

  • The risk of gastrointestinal complications is a significant concern when using oral nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen 1.
  • Topical NSAIDs, such as diclofenac gel, have been shown to be effective for pain relief with a lower risk of gastrointestinal side effects compared to oral NSAIDs 1.
  • The localized delivery of diclofenac gel reduces systemic absorption, minimizing the amount of drug that reaches the stomach lining and thereby reducing the risk of gastritis and other gastrointestinal side effects.
  • When using diclofenac gel, it is essential to follow the recommended application guidelines, such as applying a thin layer to the affected area 3-4 times daily and avoiding application to broken or irritated skin.
  • While diclofenac gel is safer for the stomach, it may be less effective than oral medications for widespread pain or severe inflammation since its effects are primarily localized to the application site.

Recommendations

  • For patients requiring pain relief with a lower risk of gastrointestinal side effects, diclofenac gel is a suitable alternative to oral ibuprofen 1.
  • Patients should be advised to follow the recommended application guidelines for diclofenac gel to minimize the risk of side effects.
  • Healthcare providers should consider the individual patient's risk factors for gastrointestinal complications when selecting a pain relief medication, and choose diclofenac gel for patients with a high risk of gastritis or other gastrointestinal side effects 1.

From the Research

Comparison of Diclofenac Gel and Ibuprofen

  • Diclofenac gel has been shown to have lower systemic bioavailability compared to oral diclofenac, which may result in fewer gastrointestinal side effects 2.
  • A study comparing the systemic bioavailability of topical diclofenac sodium gel 1% with oral diclofenac sodium found that treatment-related adverse events were mild and limited to application site reactions with diclofenac sodium gel 1% and gastrointestinal reactions with oral diclofenac 2.
  • There is no direct comparison between diclofenac gel and ibuprofen in the provided studies, but it can be inferred that diclofenac gel may cause less gastritis than oral NSAIDs like ibuprofen due to its lower systemic bioavailability.

NSAID-Induced Gastrointestinal Toxicity

  • The association between NSAIDs and upper gastrointestinal complications is well established, and evidence suggests that acid aggravates NSAID-induced injury 3.
  • Proton pump inhibitors (PPIs) have been shown to be effective in treating NSAID-related dyspepsia and healing gastric and duodenal ulcers in patients continuing to receive NSAIDs 3, 4.
  • The concomitant prescription of PPIs and NSAIDs, including diclofenac, has been found to decrease the hospitalization risk due to peptic ulcer significantly 5.

Gastroprotective Effects of PPIs

  • PPIs have been documented to significantly decrease the development of NSAID-associated ulcers, reduce the rate of NSAID-related ulcer complications, and reduce upper GI symptoms in NSAID users 4.
  • However, recent evidence suggests that the GI risks associated with NSAIDs can be potentiated when they are combined with PPIs, highlighting the need for careful consideration of the risks and benefits of co-prescribing PPIs with NSAIDs 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.